Status:
ACTIVE_NOT_RECRUITING
HOLT-ED: Holter-monitoring in End-stage Renal Disease
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Kidney Failure, Chronic
Arrhythmias, Cardiac
Eligibility:
All Genders
18+ years
Brief Summary
The main objective of this prospective cohort study is to assess arrhythmia burden and glycemic variability in a multicenter cohort of patients with end-stage renal disease using a sufficient observat...
Detailed Description
Background: The risk of dying of a cardiovascular disease is 10-20 times increased in patients dependent on dialysis treatment compared to the general population. 1/3 of these deaths is caused by arrh...
Eligibility Criteria
Inclusion
- Dialysis-treated end-stage renal disease
- Age ≥ 18 years
- Competence to understand the study rationale necessary for written informed consent
Exclusion
- Pre-existing pacemaker implantation
Key Trial Info
Start Date :
September 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 5 2024
Estimated Enrollment :
268 Patients enrolled
Trial Details
Trial ID
NCT04876963
Start Date
September 1 2021
End Date
September 5 2024
Last Update
February 26 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. of Nephrology, Rigshospitalet
Copenhagen, Denmark, 2100
2
Herlev Hospital
Herlev, Denmark
3
North Zealand Hospital
Hillerød, Denmark